Heart Valve Disease
43
5
5
18
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.0%
6 terminated out of 43 trials
75.0%
-11.5% vs benchmark
16%
7 trials in Phase 3/4
39%
7 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (43)
The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the Outcome of Patients Undergoing Surgical Cardiac Valve Replacement or Transcatheter Cardiac Valve Implantation.
The TRICURE EU Pivotal Study
LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients
Warfarin Effects on Male Fertility After Cardiac Surgery
Validation of Naevia Medical in Valvulopathies
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
Enhanced Valves Interventions and Safe AI Generated End Results
CTSN Embolic Protection Trial
Randomized On-X Anticoagulation Trial
On-X Heart Valve - 17mm Aortic and 23mm Mitral
Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery
Structural Heart and Valve Network PROSPECTIVE Registry
European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR
Prospective Randomized On-X Versus SJM Evaluation Trial
Magnetic Resonance Imaging and Fibrosis
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
High Dose Vitamin C in Cardiac Surgery Patients
ACTION - Anticoagulation Treatment Influence on Post-operative Patients
Using Beta Blockers to Treat Mitral Regurgitation